NCT07126730Not yet recruiting
Effects of EXOPULSE Mollii Suit on Spasticity and Functionality in Multiple Sclerosis Patients
Investigating the Effects of the EXOPULSE Mollii Suit on Spasticity and Functionality in Patients With Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 17 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Spasticity affects \>80% of MS patients, with 35-54% experiencing moderate-to-severe symptoms, impairing mobility and sleep. Electrical stimulation parameters (e.g., high vs. low frequency) for spasticity management remain debated. The EXOPULSE Mollii Suit uses non-invasive, low-frequency stimulation to induce reciprocal inhibition and modulate spinal interneuron activity, potentially reducing spasticity. This study aims to compare EXOPULSE Mollii + exercise vs. EXOPULSE Mollii alone in improving spasticity and function in MS.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 11 Aug 2025
- Start date
- 1 Sept 2025
- Primary completion date
- 1 Jan 2026
- Lead sponsor
- Hacettepe University
- Diseases
- Multiple sclerosis
- NCT number
- NCT07126730
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 1 Sept 2025 to the primary completion date, 1 Jan 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Received surgical intervention or botulinum toxin injection for spasticity within the last 6 months
Other illness
- Presence of any neurological condition (other than MS) that may affect independent standing or walking
Other
- Currently participating in another rehabilitation program
- Declined to participate or provide written informed consent
Who the study is looking for
- Diagnosed with MS by a neurologist according to McDonald criteria
- Age \>18 years
- EDSS score ≤6.5 (able to walk independently without assistive devices)
- Presence of spasticity
- Mini Mental State Examination (MMSE) score ≥24
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.